AMERICAN CAPITOL GROUP ON BEHALF OF SOLUTION DIAGNOSTICS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2025

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2025	—	3	1
2024	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE CORMAC GROUP, LLC	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	5
HOUSE OF REPRESENTATIVES	5
SENATE	5

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	6

AMERICAN CAPITOL GROUP ON BEHALF OF SOLUTION DIAGNOSTICS — Lobbying Disclosure | Poliscope